March S&P 500 E-Mini futures (ESH24) are up +0.04%, and March Nasdaq 100 E-Mini futures (NQH24) are up +0.23% this morning as market participants looked ahead to a fresh batch of U.S. economic data.
In Wednesday’s trading session, the benchmark S&P 500 posted a nearly 2-year high, and the blue-chip Dow and tech-heavy Nasdaq 100 notched record highs. Tesla Inc (TSLA) rose over +1% following a Bloomberg report indicating that the electric vehicle giant was gearing up to launch a revamped version of its best-selling Model Y car from its Shanghai plant. Also, Coherus BioSciences Inc (CHRS) soared more than +23% after the company announced the U.S. FDA had approved its on-body injector of cancer drug Udenyca. In addition, Cytokinetics Inc (CYTK) surged over +82% after the biotech reported positive results from a keenly awaited late-stage study of its treatment for a form of heart muscle disease. On the bearish side, Iovance Biotherapeutics Inc (IOVA) plunged over -18% after the company said the U.S. FDA had placed a clinical hold on its Phase 2 IOV-LUN-202 trial for experimental lung cancer therapy LN-145 due to a fatal adverse event.
